tiprankstipranks
Trending News
More News >
VistaGen Therapeutics (VTGN)
NASDAQ:VTGN
US Market

VistaGen Therapeutics (VTGN) Revenue

Compare
834 Followers

VistaGen Therapeutics Revenue

VistaGen Therapeutics had a revenue of -15.00K in the quarter ending Mar 31, 2025, with -106.41%. This bring the company's revenue in the last twelve months to 486.00K, Increased -30.40%. In the fiscal year ending Mar 31, 2025, VistaGen Therapeutics had annual revenue of 486.00K with -54.32% growth.
Revenue (ttm)
486.00K
Revenue Growth
-33.00%
P/S Ratio
119.99
Revenue/Employee
$10,125
Employees
48
Market Cap
$58.32M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Mar 31, 2025
486.00K-578.00K-54.32%
Mar 31, 2024
1.06M1.29M-568.72%
Mar 31, 2023
-227.00K-1.34M-120.47%
Mar 31, 2022
1.11M19.40K+1.78%
Mar 31, 2021
1.09M+∞%
Mar 31, 2020
0.00
Mar 31, 2019
0.00
Mar 31, 2018
0.00-1.25M-100.00%
Mar 31, 2017
1.25M+∞%
Mar 31, 2016
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis